- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1897-4287
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Drug therapy for hereditary cancers ; volume:9 ; number:1 ; day:6 ; month:8 ; year:2011 ; pages:1-16 ; date:12.2011
Hereditary cancer in clinical practice ; 9, Heft 1 (6.8.2011), 1-16, 12.2011
- Urheber
-
Imyanitov, Evgeny N.
- Beteiligte Personen und Organisationen
-
Moiseyenko, Vladimir M.
SpringerLink (Online service)
- DOI
-
10.1186/1897-4287-9-5
- URN
-
urn:nbn:de:1111-201607102002
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Imyanitov, Evgeny N.
- Moiseyenko, Vladimir M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cytotoxic and targeted therapy for hereditary cancers
Hereditary Ovarian Cancers
Systemic treatment for hereditary cancers: a 2012 update
Systemic therapy for hereditary cancer
Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Targetting brain cancers: approaches for therapy
Rare Cancers and Therapy
AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
Development of novel high-efficacy drugs targeting replication protein A3 in therapy resistant cancers
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances
Cytotoxic and targeted therapy for hereditary cancers
Hereditary Ovarian Cancers
Systemic treatment for hereditary cancers: a 2012 update
Systemic therapy for hereditary cancer
Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Targetting brain cancers: approaches for therapy
Rare Cancers and Therapy
AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
Development of novel high-efficacy drugs targeting replication protein A3 in therapy resistant cancers
Cytotoxic and targeted therapy for BRCA1/2-driven cancers
Systemic Therapy for Non-Melanoma Skin Cancers: Latest Advances
Cytotoxic and targeted therapy for hereditary cancers
Hereditary Ovarian Cancers
Systemic treatment for hereditary cancers: a 2012 update
Systemic therapy for hereditary cancer
Hereditary and non-hereditary branches of family eligible for BRCA test: cancers in other sites
Targeting KRAS mutant cancers: from druggable therapy to drug resistance
Targetting brain cancers: approaches for therapy
Rare Cancers and Therapy
AAV‐mediated Gene Therapy for Hereditary Deafness: Progress and Perspectives
Development of novel high-efficacy drugs targeting replication protein A3 in therapy resistant cancers
Cytotoxic and targeted therapy for BRCA1/2-driven cancers